Results 131 to 140 of about 1,273 (212)

zur Wirkung von 2,5-Dimethoxy-äthoxy-3,6-bis-äthylenimin-benzochinon-1,4 (BAYER A 139) auf die Glykolyse von Ascites-Tumorzellen [PDF]

, 1960
Holzer, H., Schneider, S., Scriba, Peter Christian   +2 more
core  

The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis. [PDF]

Am J Med Genet A
McDermott K, Bakhshaie J, Brewer J, Vranceanu AM.   +3 more
europepmc   +1 more source

Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. [PDF]

Clin Trials
Merker VL, Gross AM, Widemann BC, Plotkin SR.   +3 more
europepmc   +1 more source

[Clinical characterization in patients with neurocutaneous syndrome]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Castañeda Y, Juárez-Melchor D, Vera-Loaiza A, Pérez-Arzola AA, Crisanto-López IE, Rodríguez-Hurtado PO.   +5 more
europepmc   +1 more source

[⁸⁹Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial. [PDF]

BMJ Open
Douwes JPJ, Tops AL, Dibbets-Schneider P, Verbist BM, Fuentealba Bassaletti CA, Jansen JC, Koetsier KS, van Dam VS, Koot RW, van Velden FHP, Pool M, Vugts D, Schopman JE, Goeman JJ, De Geus-Oei LF, Hensen EF, Gelderblom HA.   +16 more
europepmc   +1 more source

Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1. [PDF]

Bone Res
Kovaci F, Goachet C, Perrin S, Slimani L, Coulpier F, Tilotta F, Topilko P, Colnot C.   +7 more
europepmc   +1 more source

Neurofibromatosis 2 : Genetic Analysis of Mild Disease, and Biology of the Gene Product, Merlin [PDF]

, 2000
Sainio, Markku
core  

A Lesson Learned in Managing Traumatic Cervical Neurofibromatosis Type 1. [PDF]

Cureus
Syed Afandi SFS, Ibrahim R, Mohamad Yunus MR.   +2 more
europepmc   +1 more source

Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments. [PDF]

J Neurooncol
Barton B, Wolters PL, Walsh KS, Ullrich NJ, Rosser T, Tonsgard J, Viskochil D, Schorry E, Klesse LJ, Fisher MJ, Gutmann DH, Packer RJ, Korf B, Acosta MT, North KN, Payne JM, NF Clinical Trials Consortium.   +16 more
europepmc   +1 more source

Innovative designs to improve trials in the neurofibromatoses [PDF]

Dhaenens, Britt
core   +6 more sources